Semaglutide is a peptide medication that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)
Dosing Protocols and Administration Understanding proper dosing helps maximize effectiveness while minimizing side effects
Additionally, fluctuations in the duration of your menstrual cycleeither shorter or longer cycleshave been reported
Additionally, for the outcome of completed suicide, the generalizability of findings to the broader population of interest was limited (indirectness), as the evidence largely originated from studies involving overweight or obese patients with severe metabolic comorbidities
It also causes sunburn, which can lead to peeling, sensitivity, and long-term pigmentation
By January 2024, monthly Medicaid spending on Wegovy alone exceeded $51 million, and by October 2024, it had grown to $192 million